Why the study?
Perindopril offers the advantage of a single daily dose empirically taken in the morning, but the influence of administration timing on circadian blood pressure in type 2 diabetes with untreated stage 1 hypertension was unclear.
Does morning administration of perindopril improve 24-hour systolic blood pressure compared to evening administration in type 2 diabetes individuals with stage 1 hypertension?
Does morning administration of perindopril improve 24-hour systolic blood pressure compared to evening administration in type 2 diabetes individuals with stage 1 hypertension?
Morning versus evening administration of perindopril 10 mg showed no significant difference in 24-hour blood pressure control in Cameroonian patients with type 2 diabetes and stage 1 hypertension.
Answers are grounded in this paper and cite their sources.
Timing of perindopril does not affect circadian BP control in T2D; leaves open optimal dosing schedule for this population.
Renin-angiotensin system antagonists are the mainstays of blood pressure (BP) lowering strategies in people with diabetes. Perindopril a long half-life Angiotensin Converting Enzyme (ACE) inhibitor offers the advantage of a single daily dose, usually empirically taken in the morning. We therefore aimed to assess the influence of time of administration on the effect of Perindopril on circadian BP in type 2 diabetes (T2D) individuals with previously untreated stage 1 hypertension.
No takes yet. Share an insight, caveat, or question.
Mfeukeu et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: